View in EDS

Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.

Saved in:
Bibliographic Details
Title: Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.
Authors: Boekhoff MR; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Bouwmans R; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Doornaert PAH; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Intven MPW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Lagendijk JJW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., van Lier ALHMW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Rasing MJA; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., van de Ven S; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Meijer GJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Mook S; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.
Source: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2022 Mar 17; Vol. 34, pp. 82-89. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology Country of Publication: Ireland NLM ID: 101713416 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6308 (Electronic) Linking ISSN: 24056308 NLM ISO Abbreviation: Clin Transl Radiat Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35372703
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boekhoff+MR%22">Boekhoff MR</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bouwmans+R%22">Bouwmans R</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Doornaert+PAH%22">Doornaert PAH</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Intven+MPW%22">Intven MPW</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lagendijk+JJW%22">Lagendijk JJW</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Lier+ALHMW%22">van Lier ALHMW</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rasing+MJA%22">Rasing MJA</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Ven+S%22">van de Ven S</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Meijer+GJ%22">Meijer GJ</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mook+S%22">Mook S</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101713416%22">Clinical and translational radiation oncology</searchLink> [Clin Transl Radiat Oncol] 2022 Mar 17; Vol. 34, pp. 82-89. <i>Date of Electronic Publication: </i>2022 Mar 17 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ireland+Ltd%2E+on+behalf+of+European+Society+for+Radiotherapy+and+Oncology%22">Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>101713416 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2405-6308 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224056308%22">24056308 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Radiat Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35372703
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ctro.2022.03.008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 82
    Titles:
      – TitleFull: Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boekhoff MR
      – PersonEntity:
          Name:
            NameFull: Bouwmans R
      – PersonEntity:
          Name:
            NameFull: Doornaert PAH
      – PersonEntity:
          Name:
            NameFull: Intven MPW
      – PersonEntity:
          Name:
            NameFull: Lagendijk JJW
      – PersonEntity:
          Name:
            NameFull: van Lier ALHMW
      – PersonEntity:
          Name:
            NameFull: Rasing MJA
      – PersonEntity:
          Name:
            NameFull: van de Ven S
      – PersonEntity:
          Name:
            NameFull: Meijer GJ
      – PersonEntity:
          Name:
            NameFull: Mook S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 03
              Text: 2022 Mar 17
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2405-6308
          Numbering:
            – Type: volume
              Value: 34
          Titles:
            – TitleFull: Clinical and translational radiation oncology
              Type: main
ResultId 1